Evidence map›Paper›PMID 38745909›Full record

ArticleFrontiers in molecular biosciences2024

Yulieth Torres-Llanos, Jovanny Zabaleta, Nataly Cruz-Rodriguez, Sandra Quijano, Paula Carolina Guzmán, Iliana de Los Reyes, Nathaly Poveda-Garavito, Ana Infante, Liliana Lopez-Kleine, Alba Lucía Combita

Abstract read
In one paragraph

Article in Frontiers in molecular biosciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yulieth Torres-LlanosCancer Biology Group, Instituto Nacional de Cancerología, Bogotá, Colombia.
Jovanny ZabaletaDepartment of Interdisciplinary Oncology, Louisiana State University Health Sciences Center, New Orleans, LA, United States.
Nataly Cruz-RodriguezVersiti Blood Research Institute, Milwaukee, WI, United States.
Sandra QuijanoDepartment of Microbiology, Pontificia Universidad Javeriana, Bogotá, Colombia.
Paula Carolina GuzmánDepartment of Pediatrics, Hospital Militar Central, Bogotá, Colombia.
Iliana de Los ReyesDepartment of Pediatrics, Hospital Militar Central, Bogotá, Colombia.
Nathaly Poveda-GaravitoCancer Biology Group, Instituto Nacional de Cancerología, Bogotá, Colombia.
Ana InfanteDepartment of Pediatrics, Hospital Universitario San Ignacio, Bogotá, Colombia.
Liliana Lopez-KleineDepartment of Statistics, Universidad Nacional de Colombia, Bogotá, Colombia.
Alba Lucía CombitaCancer Biology Group, Instituto Nacional de Cancerología, Bogotá, Colombia.

Funding

Translational Genomics Core (TGC)P20GM121288 · NIGMS · LSU HEALTH SCIENCES CENTER · PI Arunava Roy · 2017 to 2026
$22.4M
NIGMS NIH HHS P20 GM121288
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

B-cell acute lymphoblastic leukemiabiomarkersDNA methylationgene expressionMRDprognosistreatment response

Identifiers

PMID38745909
PMCPMC11091394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.